Unosi

• The use of unproven drugs for COVID-19 treatment in people living with HIV. (2023-06)

  J. Kowalska, B. Rozplochowski, A. Harxhi, L. Fleischhans, S. Antonjak, D. Gokengin, A. Vassilenko, K. Almla, A. Papadopoulus, R. Matulionyte, N. Rukhadze, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, A. Verhaz, N. Yancheva, J. Begovac, A. Skrzat-Klapaczyńska, C. Oprea, A. Horban, The use of unproven drugs for COVID-19 treatment in people living with HIV., Jun, 2023

• Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2022)

  J. Kowalska, D. Bursa, D. Jilich, S. Antoniak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, L. Fleishhans, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, A. Skrzat-Klapaczyńska, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, 2022

• Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group (2020-10)

  T. Balayan, J. Begovac, A. Skrzat-Klapaczyńska, P. Bukovinova, I. Aho, I. Alexiev, D. Salemovic, D. Gokengin, T. Harxhi, Đ. Jevtovic, K. Kase, A. Verhaz, N. Yancheva, O. Yurin, A. Horban, J. Kowalska, Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group, HIV MEDICINE, Vol. 21, No. 9, pp. 1 - 6, Oct, 2020

• Viral hepatitis in HIV-positive patients - testing, prophylaxis and treatment in Central and Eastern Europe (2020-10)

  K. Kase, A. Skrzat-Klapaczyńska, R. Matulionyte, V. Mulabdic, P. Bukovinova, A. Vassilenko, N. Bolokadze, D. Jilih, A. Verhaz, D. Gokengin, G. Dragović-Lukić, A. Horban, Viral hepatitis in HIV-positive patients - testing, prophylaxis and treatment in Central and Eastern Europe, HIV MEDICINE, Vol. 20 (2019), No. Suppl.9;, pp. 270 - 271, Oct, 2020

• Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19) (2021-12)

  B. Lakatos, J. Kowalska, S. Antoniak, D. Gokengin, J. Begovac, A. Vassilenko, p. wasilevski, l. fleischhans, D. Lakatos, R. Matulionyte, K. Kase, A. Papadopoulus, N. Rukhadze, A. Harxhi, S. Hofman, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, C. Oprea, Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19), HIV MEDICINE, Vol. 23, No. 1468-1293, pp. 1 - 8, Dec, 2021

• The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group (2022-05)

  J. Kowalska, C. Bienkowski, L. Fleishhans, S. Antoniak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Gokengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Jancheva, J. Begovac, A. Horban, The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group, Viruses Journal, Vol. 14, No. 5, pp. 1 - 12, May, 2022

• The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group (2022-06)

  A. Skrzat-Klapaczyńska, J. Kowalska, S. Antonyak, T. Balayan, J. Begovac, D. Bursa, G. Dragović-Lukić, D. Gokengin, L. Afonina, A. Harxhi, D. Jilich, K. Kase, A. Verhaz, B. Lakatos, M. Mardarescu, R. Matulionyte, A. Panteleev, A. Papadopoulus, L. Sojak, C. Oprea, J. Tomazic, A. Vassilenko, M. Vasyliev, A. Verhaz, N. Yancheva, O. Yurin, A. Horban, The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, Vol. 19 (13), No. 19(13), pp. 1 - 9, Jun, 2022

• Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023)

  A. Kerstin, J. Kowalska, R. Matulionyte, V. Mulabdic, A. Vassilenko, N. Bolokadze, D. Jilich, S. Antoniak, C. Oprea, T. Balayan, A. Harxhi, A. Papadopoulus, B. Lakatos, M. Vasylyev, J. Begovac, N. Yancheva, A. Streinu-Cercel, A. Verhaz, D. Gokengin, G. Dragović-Lukić, L. Sojak, A. Skrzat-Klapaczyńska, Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group, EXPERT REVIEW OF VACCINES, Vol. 11, pp. 1 - 9, 2023

• PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future (2023-01)

  D. Gokengin, D. Bursa, A. Skrzat-Klapaczyńska, I. Alexiev, E. Arsikj, T. Balayan, J. Begovac, A. Cicic, G. Dragović-Lukić, A. Harxhi, K. Aimla, B. Lakatos, R. Matulionyte, V. Mulabdić, C. Oprea, A. Papadopoulus, N. Rukhadze, D. Sedlacek, L. Sojak, J. Tomazic, A. Vassilenko, M. Vasyliev, A. Verhaz, A. Verhaz, N. Yancheva, O. Yurin, J. Kowalska, PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future, Vaccines , Vol. 11, No. 1, pp. 1 - 12, Jan, 2023

• Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023-05)

  A. Kerstin, J. Kowalska, R. Matulionyte, V. Mulabdić, A. Vassilenko, N. Bolokadze, D. Jilich, S. Antoniak, C. Oprea, T. Balayan, A. Harxhi, A. Papadopoulus, B. Lakatos, M. Vasylyev, J. Begovac, N. Yancheva, A. Streinu-Cercel, D. Gokengin, A. Verhaz, G. Dragović-Lukić, Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group, Vaccines, Vol. 11(5), pp. 980 - 987, May, 2023

• Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2021-10)

  J. Kowalska, D. Bursa, D. Jilich, S. Antonjak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, A. Verhaz, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, ePoster. PE4/18ecee.president@gmail.com, Oct, 2021

• Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group (2022-07)

  J. Kowalska, M. Vasyliev, A. Harxhi, L. Fleischhans, S. Antoniak, D. Gokengin, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, B. Lakatos, G. Dragović-Lukić, D. Jilich, A. Verhaz, A. Verhaz, J. Begovac, A. Skrzat-Klapaczyńska, C. Oprea, Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group, Jul, 2022